Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-05 10:55 am Sale | 13G | Nuvectis Pharma Inc. NVCT | Pontifax Management 4 G.P. (2015) Ltd. | 288,873 1.500% | -628,527 (-68.51%) | View |
| 2024-02-28 08:37 am Purchase | 13G | Nuvectis Pharma Inc. NVCT | Mosseri Marlio Charles | 2,595,000 15.000% | 214,824 (+9.03%) | View |
| 2024-02-06 08:47 am Purchase | 13G | Nuvectis Pharma Inc. NVCT | Pontifax Management 4 G.P. (2015) Ltd. | 917,400 5.300% | 917,400 (New Position) | View |
| 2024-01-31 7:34 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Poradosu Enrique | 1,503,819 8.700% | 285,500 (+23.43%) | View |
| 2024-01-31 7:33 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Shemesh Shay | 1,491,955 8.600% | 286,090 (+23.72%) | View |
| 2024-01-30 9:01 pm Sale | 13G | Nuvectis Pharma Inc. NVCT | Peters Thomas Phineas | 908,475 5.200% | -39,183 (-4.13%) | View |
| 2023-04-03 08:15 am Purchase | 13G | Nuvectis Pharma Inc. NVCT | Peters Thomas Phineas | 947,658 6.400% | 947,658 (New Position) | View |
| 2023-02-13 5:16 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Shemesh Shay | 1,205,865 8.200% | 1,205,865 (New Position) | View |
| 2023-02-13 5:15 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Poradosu Enrique | 1,218,319 8.300% | 1,218,319 (New Position) | View |
| 2023-01-09 10:19 am Purchase | 13G | Nuvectis Pharma Inc. NVCT | Mosseri Marlio Charles | 2,380,176 16.300% | 977,620 (+69.70%) | View |
| 2022-03-28 6:46 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Mosseri Marlio Charles | 1,402,556 11.030% | 1,402,556 (New Position) | View |
| 2022-03-28 5:22 pm Purchase | 13D | Nuvectis Pharma Inc. NVCT | BENTSUR RON | 2,728,700 21.460% | 2,728,700 (New Position) | View |
| 2022-02-15 5:18 pm Purchase | 13G | Nuvectis Pharma Inc. NVCT | Mosseri Marlio Charles | 1,265,200 9.950% | 1,265,200 (New Position) | View |